2005 Jan | Feb | March | April | May | June | July | Aug | Sep | Oct | Nov | Dec |
December
2005 |
Dec 24/31 |
Denise Szpunar
The e-mail address for Denise Szpunar should have read denise.szpunar@clha.nhs.uk,
not as stated (PJ, 3 December, p683).
Specials
The beginning of the second paragraph of the conclusion of our special
feature last week (17 December, p746 PDF (70K)) should have read: “The
use of specials for babies and children is being addressed. However,
a problem clearly still exists with liquid medicines because a sufficient
number
of appropriate licensed products simply do not exist.” |
Dec 10 |
Viroflu
Viroflu (inactivated influenza vaccine) prefilled syringes will not be available
until 2006 and not as stated last week (p683 PDF (50K)). |
November
2005 |
Nov 12 |
ADDITIONAL INFORMATION: Ginseng
The standardised ginseng extract described in a news
item (PJ, 29 October, p541)
was made up of 80 per cent poly-furanosyl-saccharides and 10 per cent protein
formulated from the roots of North American ginseng. The capsules contained
200mg
of freeze-dried extract. |
Nov 5 |
Contraception
The telephone number for ordering leaflets on long-acting reversible contraception
is 0870 1555455, quoting reference N0916, not as stated last week (PJ, 29 October,
p545). |
October
2005 |
Oct 29 |
Newham PCT
Newham Primary Care Trust is investigating a complaint against the PCT alone
and not the PCT and North East London Local Pharmaceutical Committee, as stated
(PJ, 15 October, p474).
NHS Innovations award
The Guildford and Waverley Primary Care Trust team which won the NHS
innovations award (PJ, 22 October, p506) also included Louise Robinson
and Tina McKee, who were not pictured.
Picture credit
The credit for the image used on p499 and p507 last week (PJ, 22 October)
should have read “Design for patient safety. Crown Copyright 2005.” |
Oct 22 |
Letter title
The letter from Chris Morris (PJ, 15 October, p482) was printed with an incorrect
title. The title should have read “Why not give pharmacists the final
say?”.
Tarceva
Tarceva has been launched by Roche, not Abbott as stated (PJ, 1 October,
p401). |
Oct 15 |
CORRECTION Pharmacy diabetes Smartgroup
The email address to join the Diabetes UK Smartgroup (PJ, 8 October, p435) is
pharmacydiabetesnetwork-subscribe@smartgroups.com. “Smartgroups” is
not hyphenated.
CLARIFICATION Healthy returns
Payments presented at the UniChem convention for services (PJ, 8 October,
p448 PDF (90K))
were incorrect. The correct fees are: warfarin clinic, £85
per patient per year; hip fracture review clinic, £20 per consultation;
and stroke clinic, £500 set up fee plus £300 for two days each month. |
September
2005 |
Sep 24 |
Book review
The ISBN number listed for the book ‘Essentials of economic evaluation
in healthcare’ (PJ, 10 September, p315)
was incorrect. The correct number is ISBN 0 85369 574 1
Broad spectrum
The Table in the Broad spectrum article “Thinking the unthinkable — pushing
the boundaries of pharmacy skill mix”, which appeared in the 10 September
issue (p306), should have been titled “Task/competency matrix for
applying skill mix”. |
Sep 10 |
Sinthrome
The SPC change
for Sinthrome (acenocoumarol) tablets (PJ, 20 August, p223) was
incorrect. Alliance now says that cranberry juice should be avoided in patients
taking Sinthrome due to a theoretical risk of enhanced anti-coagulation, not
coagulation. |
August
2005 |
August 27 |
Retention fees
Retention fees for non-practising pharmacists are to rise by 30 per cent from £46
to £60, and not 25 per cent as previously stated (PJ, 13 August,
p199). |
August 13 |
Stanley Blum’s letter
Stanley Blum mentioned Staphylococcus typhimurium in his letter (PJ, 30 July,
p139). It should have read Salmonella
typhimurium.
Howard McNulty’s letter
Howard McNulty’s letter (PJ, 6 August, pp162–3) was published
without several lines due to a production error. The first column of
p163 should have started
“national boards looking after professional
interests there will need to be clearer demarcation and funding of these
two separate roles and for the boards. It will be important to develop
separate professional and regulatory budget elements to ensure both are
able to break even. Publications should be used to subsidise professional
elements and not regulatory ones. Other professional bodies are better
at looking after students and”. |
August 6 |
MUR forms
Pharmacists in England and Wales will be using the same medicines use review
forms to record the MUR process and not different forms for this process as
suggested in a recent news
item (PJ, 16 July, p72). However, pharmacists in
Wales will use two different forms to register themselves and their premises
to undertake MURs and another form to claim reimbursement for MURs undertaken.
These three forms are used in Wales instead of the Prem1 form used in England.
|
July
2005 |
July 30 |
Grisol
Distribution, supply and stock queries for Grisol AF (griseofulvin) (PJ, 23 July,
p111) are handled by M & A Pharmachem (tel 01942 816184).
|
July 23 |
Bill Brookes
Bill Brookes has asked us to point out an error in his letter (PJ, 16 July, p84).
What he intended to write under point 2(a) was: “Charge a realistic but
not exorbitant rate to those seeking rest and recuperation.”
Community collaborative
In last week’s report of concern that pharmacies were not being reimbursed
costs incurred in taking part in the Department of Health’s community pharmacy
framework collaborative
(PJ, 16 July, p75), the National Pharmacy Association claimed the scheme had £4m
of DoH funding. The
correct figure is £2.1m.
Gideon Kotey
In our recent report on the Pharmaceutical Care Awards for 2004 (PDF 730K), the
name
of
Gideon Kotey, was misspelt in a photograph caption
(PJ, 2 July, p16).
Reshma Gandecha
We have been asked to point out that Reshma Gandecha is a health informatics
researcher and a pharmacist and that the views expressed in her article “What
the national IT programme means for pharmacy and pharmacists” (PJ,
9 July, p56 PDF (260K)) do not necessarily reflect those of Essex Strategic Health
Authority
or
the Essex NPfIT programme, although her NPfIT research covers the NPfIT trajectory
in Essex and Cambridgeshire.
|
July 16 |
Lithium clinic
In the report of the lithium clinic that won a Pharmaceutical Care Award (PJ,
2 July, p16 PDF (730K)) the third sentence in the fourth paragraph should have
read: “92
per cent have had their lithium levels checked within the previous three months
and 99 per cent their serum creatinine and thyroid stimulating hormone levels
checked within the previous six months.”
Radioactivity dose
The dose of radioactivity above which advisory committee approval is required
0.1mSv, not 1mSv as stated in the article on microdoses in last week’s
Journal (PJ, 9 July, p54).
|
July 9 |
CLARIFICATION: Rajiv Sarna
Our report of the prosecution of Rajiv Sarna for making a fraudulent Essential
Small Pharmacy Scheme claim (PJ, 4 June, p668), was based on information provided
by NHS Counter Fraud Services. NHS Counter Fraud Services now accepts that Mr
Sarna would have been entitled to £15,600 of the £23,000 he claimed.
Mr Sarna returned £23,000 to the
NHS before his trial, not
before sentencing as reported,
and will now receive a refund
of £15,600.
CORRECTION: New member fee
The Royal Pharmaceutical Society’s new member registration fee is £125,
not £110 as stated in last week’s issue (PJ, 2 July, p10). |
June
2005 |
June 18 |
Aloxi
Palonosetron (Aloxi) is licensed for the prevention of nausea and vomiting associated
with moderately emetogenic cancer chemotherapy, not just acute nausea and vomiting,
as stated last week (PJ, 11 June, p701).
|
June 11 |
Etanercept
Etanercept is licensed for the treatment of adults with moderate to severe plaque
psoriasis and not as stated in our CPD article (PDF 310K) last week (4 June,
pp689–92).
The recommended dose for this indication is 25mg twice weekly. The licence for
this indication was granted in November 2004.
|
June 4 |
Alan Nathan
Alan Nathan, pharmacy writer and consultant, is a visiting lecturer at King’s
College London and not as stated last week (PJ, 28 May, p652).
Duac Once Daily gel
The price of Duac Once Daily gel (Stiefel) 50g is £19.90, not £19.95
as The Journal was previously informed (PJ, 7 May, p541).
Hibiscrub
Hibiscrub is a Regent Medical product, not an SSL product as stated previously
(PJ, 16 April, p449).
Hycosan eye drops
Hycosan (hyaluronic acid) eye drops 0.1 per cent (Bausch & Lomb UK)
are classified as a medical device, not a GSL product as The Journal was previously informed (PJ, 21 May, p609). |
May
2005 |
May 28 |
EHC story
The paper about emergency hormonal contraception referred to in last week’s
Journal (p604) was published in the Lancet (2005;365:1668), not the BMJ as stated.
Technicians
Lesley Morgan would like to see community pharmacy technicians’ careers
developing in a similar way to those of hospital technicians, not pharmacists,
as stated in last week’s issue (p614). |
May 14 |
Vitalux Plus
Vitalux Plus (Novartis) is not classified as a pharmacy medicine as previously
stated (PJ, 30 April, p515). The product is a food supplement and is not classified
as a medicinal product. |
May 7 |
Jennie Hammond
Jennie Hammond is still a pharmacist and not a former pharmacist as stated previously
(PJ, 2 April, p387). |
April
2005 |
April 16 |
MRSA colonisation
The number of people in the community carrying methicillin resistant Staphylococcus
aureus in their nose is uncertain and not as stated in the news story (PJ, 12
March, p287). |
April 9 |
Medicines in Uganda
The contact e-mail address in our article on bringing medicines information to
Uganda (PJ, 26 March, p369) is stevensambya@ yahoo.co.uk and not as stated.
Discharge planning
Our Broad spectrum article on communicating information (PJ, 19 March,
p332) referred to a “Discharge planning and
medicines” toolkit. We have been asked to point out that this
toolkit is the joint work of the Royal Pharmaceutical Society, the Pharmaceutical
Services Negotiating Committee, the Guild of Healthcare Pharmacists and
the Primary Care Pharmacists Association. |
April 2 |
Durex recall
The letter C at the end of the batch numbers for recalled Durex condoms may appear
as a “€” and not a “_” as stated last week (PJ, 26 March,
p357) |
March
2005 |
March 26 |
Avastin
The telephone number for information about Avastin is 0800 328 1629, and not
as stated last week (PJ, 19 March, p331). |
March 19 |
CLARIFICATION: Equasym
Equasym XL (methylphenidate hydrochloride) is a Schedule 2 Controlled Drug (PJ,
26 February, p231). |
February
2005 |
Feb 26 |
Additional information: Author details
Further to the authors’ information published (PJ, 29 January,
p117 PDF (75K)), Adele Mackellar is employed by Wythenshawe Hospital, South Manchester
University Hospitals
Trust, Jennifer Silverthorne is employed by Hope Hospital, Salford Royal Hospitals
NHS Trust, and Suzanne Thomas is employed by Manchester Royal Infirmary, Central
Manchester Healthcare NHS Trust. |
Feb 19 |
Zevalin
Zevalin (ibritumomab tiuxetan) was launched last year by Schering Health Care,
not Schering-Plough as stated last week (PJ, 12 February, p171).
Academica Ltd
The supplier of historical pharmacy replicas recently acquired by Ralph
Higson, MRPharmS, is called Academica Ltd, not Academia as previously
stated (PJ, 5 February, p142). |
Feb 12 |
Medicines Compendium
The e-mail address for ordering copies of the Medicines Compendium 2005 is compendium@omsg.co.uk
and not as stated last week (PJ, 5 February p143). |
January
2005 |
January 29 |
BNF CORRECTION: DaunoXome
There is an error in 48th edition of the British National Formulary (September
2004) for the DaunoXome (daunorubicin) entry (section 8.1.2, p427). The side
heading reads “lipid formulation for intrathecal use” but should
read “lipid formulation”. DaunoXome is
for intravenous use, not for intrathecal use. The error will be corrected in
BNF 49 (March 2005).
Galanthamine structure
There was a mistake in the chemical structure of galanthamine printed in the
18/25 December 2004 issue of The Journal (p906). The correct structure is printed
below.
|
January 22 |
Harrow and Hillingdon branch meetings
Incorrect information about meetings of the Royal Pharmaceutical Society’s
Harrow and Hillingdon branch was given in Network News (centre pull-out, PJ,
1/8 January). The correct
dates and topics are as follows:
25 January, “Meet your primary care trust”; 1 March, oncology
12 April, osteoporosis; 10 May, annual general meeting plus subject to be arranged
7 June, subject to be arranged.
Practice research awards
The contact for the practice
research awards offered by the Pharmacy
Practice Research Trust (PJ, 15 January, p65) is Beth Allen,
research administrator at the Royal Pharmaceutical Society
(tel 020 7572 2466; e-mail: beth.allen@rpsgb.org) |
January 1/8 |
Code of Ethics: Online pharmacy service
There were two errors in the text supplied to The Journal for the Code of Ethics
changes agreed at the December 2004 Council meeting (PJ, 18/25 December 2004,
p889). Both relate to the revision of Service Specification 9, concerning online
pharmacy services.
In the introductory text, the penultimate sentence should
read: “Details of how to confirm the registration status of the pharmacy
and pharmacists must be provided.”
In paragraph (c)(i) the second sentence
should read: “A record must be kept of the pharmacist assuming professional
responsibility for the recommendation and this pharmacist must be identified
to the patient.”
Sam Bolanakis
Sam Bolanakis’s name was misspelt in our December issue of Prescribing & Medicines
Management (PM3). |
Acrobat
Reader